APFED sets Eos Connection 2026 for July in Denver and online

The American Partnership for Eosinophilic Disorders will mark its 25th anniversary with Eos Connection 2026, a hybrid conference for patients, families and experts July 9-12 in Aurora, Colorado, and virtually. The event is designed to provide education, support and access to the latest diagnostics and treatments for eosinophilic diseases. Why it matters: - Eos Connection 2026 is built for people living with eosinophilic diseases who want practical answers, expert guidance and peer support. - The conference centers on conditions that can affect everyday health, diagnosis and treatment decisions, making education and early access to information especially important. - APFED is using its 25th anniversary event to expand awareness and connect patients, caregivers and clinicians in one place. What happened: - The American Partnership for Eosinophilic Disorders opened registration for Eos Connection 2026. - The conference will take place July 9-12, 2026, at the Hyatt Regency Aurora-Denver Conference Center and virtually. - APFED is marking its 25th anniversary with the event. - The conference is aimed at individuals and families affected by eosinophilic diseases, as well as anyone interested in learning about the conditions. The details: - Programming will cover diagnostics, treatments, nutrition, mental health and everyday challenges. - Attendees will be able to engage directly with experts and peers. - The agenda includes special youth programming. - Registration includes live sessions, networking opportunities, conference materials and on-demand content after the event. - Free virtual access is available through APFED’s conference page . - The conference is being held in collaboration with Children’s Hospital Colorado. - Sanofi and Regeneron are supporting the event as education partners. - APFED says the conference is designed for people who are newly diagnosed, seeking answers or have lived with eosinophilic disease for years. Between the lines: - The event reflects a broader push to pair patient education with access to specialists, which can help families navigate a condition that is often complex and underrecognized. - The involvement of a children’s hospital and major pharmaceutical companies suggests the conference is positioning itself as both a patient support event and a medical education forum. - The anniversary framing gives APFED a chance to reinforce its role as a long-term advocate in the eosinophilic disease community. What’s next: - APFED will host the hybrid conference in July 2026. - Organizers are expected to share more details about sessions, speakers and conference logistics ahead of the event. - Patients and caregivers can register now for in-person or virtual attendance through APFED’s website. - APFED will continue promoting education, awareness, research, advocacy and support for eosinophil-associated disorders.